Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
Avenell A, Gillespie WJ, Gillespie LD, O'Connell D
The Cochrane database of systematic reviews · 164 citas
Cómo se estudió
- Diseño
- Metaanálisis (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Eventos clínicos como enfermedad o muerte
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- Chief Scientist Office
Según 1 financiador declarado.
Publicación
- Publicado
- 2009-04-15 · Cochrane Database Syst Rev · número 2 · pág. CD000227
- Editorial
- Elsevier BV
- Citado
- 661 citas
- Referencias
- 213 trabajos
- Acceso
- De pago
- Áreas de investigación
- Vitamin D Research Studies · Bone health and osteoporosis research · Vitamin K Research Studies
- Palabras clave
- vitamin D, vitamin D analogs, osteoporosis, postmenopausal osteoporosis, involutional osteoporosis, fracture prevention, hip fracture, vertebral fractures, calcium supplementation, hypercalcemia, 1,25-dihydroxyvitamin D3, community-dwelling older adults, fall prevention, falls in older adults
- MeSH
- humans, osteoporosis, osteoporosis, postmenopausal, hydroxycholecalciferols, calcitriol, vitamins, vitamin d, dietary supplements, aged, frail elderly, female, male, bone density conservation agents, fractures, bone, randomized controlled trials as topic
4 autores
- Alison Avenell🇬🇧University of Aberdeen
- William John Gillespie🇬🇧University of Hull
- Lesley Diane Gillespie🇳🇿University of Otago
- Dianne L. O’Connell🇦🇺Cancer Council NSW
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Vitamin D and related compounds have been used to prevent osteoporotic fractures in older people.
Objectives
To determine the effects of vitamin D or related compounds, with or without calcium, for preventing fractures in older people.
Search strategy
We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register, the Cochrane Central Register of Controlled Trials (The Cochrane Library 2007, Issue 3), MEDLINE, EMBASE, CINAHL, and reference lists of articles. Most recent search: October 2007.
Selection criteria
Randomised or quasi-randomised trials comparing vitamin D or related compounds, alone or with calcium, against placebo, no intervention, or calcium alone, reporting fracture outcomes in older people.
Data collection and analysis
Two authors independently assessed trial quality, and extracted data. Data were pooled, where admissible, using the fixed-effect model, or random-effects model if heterogeneity between studies appeared high.
Main results
Forty-five trials were included. Vitamin D alone appears unlikely to be effective in preventing hip fracture (nine trials, 24,749 participants, RR 1.15, 95% CI 0.99 to 1.33), vertebral fracture (five trials, 9138 participants, RR 0.90, 95% CI 0.42 to 1.92) or any new fracture (10 trials, 25,016 participants, RR 1.01, 95% CI 0.93 to 1.09).Vitamin D with calcium reduces hip fractures (eight trials, 46,658 participants, RR 0.84, 95% CI 0.73 to 0.96). Although subgroup analysis by residential status showed a significant reduction in hip fractures in people in institutional care, the difference between this and the community-dwelling subgroup was not significant (P = 0.15).Overall hypercalcaemia is significantly more common in people receiving vitamin D or an analogue, with or without calcium (18 trials, 11,346 participants, RR 2.35, 95% CI 1.59 to 3.47); this is especially true of calcitriol (four trials, 988 participants, RR 4.41, 95% CI 2.14 to 9.09). There is a modest increase in gastrointestinal symptoms (11 trials, 47,042 participants, RR 1.04, 95% CI 1.00 to 1.08, P = 0.04) and a small but significant increase in renal disease (11 trials, 46,537 participants, RR 1.16, 95% CI 1.02 to 1.33).
Authors' conclusions
Frail older people confined to institutions may sustain fewer hip fractures if given vitamin D with calcium. Vitamin D alone is unlikely to prevent fracture. Overall there is a small but significant increase in gastrointestinal symptoms and renal disease associated with vitamin D or its analogues. Calcitriol is associated with an increased incidence of hypercalcaemia.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.